Drug
Relacorilant Under Fasted Conditions
Relacorilant Under Fasted Conditions: highest development phase Phase 1, developed by Corcept Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Corcept Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Relacorilant under fasted conditions NCT06094738 | Phase 1 | Healthy |
Latest
No recent events.
Follow Relacorilant Under Fasted Conditions on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.